CL2014003377A1 - Método para detectar e identificar escherichia coli enterohemorrágica. - Google Patents

Método para detectar e identificar escherichia coli enterohemorrágica.

Info

Publication number
CL2014003377A1
CL2014003377A1 CL2014003377A CL2014003377A CL2014003377A1 CL 2014003377 A1 CL2014003377 A1 CL 2014003377A1 CL 2014003377 A CL2014003377 A CL 2014003377A CL 2014003377 A CL2014003377 A CL 2014003377A CL 2014003377 A1 CL2014003377 A1 CL 2014003377A1
Authority
CL
Chile
Prior art keywords
identify
detect
escherichia coli
enterohemorrhagic escherichia
enterohemorrhagic
Prior art date
Application number
CL2014003377A
Other languages
English (en)
Spanish (es)
Inventor
Patrick Fach
Sabine Delannoy
Lothar Beutin
Original Assignee
Agence Nationale De Securite Sanitaire De L Alimentation De L Environnement Et Du Travail
Bundesinstitut für Risikobewertung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence Nationale De Securite Sanitaire De L Alimentation De L Environnement Et Du Travail, Bundesinstitut für Risikobewertung filed Critical Agence Nationale De Securite Sanitaire De L Alimentation De L Environnement Et Du Travail
Publication of CL2014003377A1 publication Critical patent/CL2014003377A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/143Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CL2014003377A 2012-06-14 2014-12-12 Método para detectar e identificar escherichia coli enterohemorrágica. CL2014003377A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12171941.3A EP2674501A1 (en) 2012-06-14 2012-06-14 Method for detecting and identifying enterohemorrhagic Escherichia coli

Publications (1)

Publication Number Publication Date
CL2014003377A1 true CL2014003377A1 (es) 2015-08-07

Family

ID=48949190

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014003377A CL2014003377A1 (es) 2012-06-14 2014-12-12 Método para detectar e identificar escherichia coli enterohemorrágica.

Country Status (12)

Country Link
US (1) US10190175B2 (enExample)
EP (2) EP2674501A1 (enExample)
JP (1) JP6166365B2 (enExample)
KR (1) KR102065053B1 (enExample)
CN (1) CN104619860B (enExample)
AU (1) AU2013276084B2 (enExample)
BR (1) BR112014031370B1 (enExample)
CA (1) CA2875919C (enExample)
CL (1) CL2014003377A1 (enExample)
ES (1) ES2659469T3 (enExample)
MX (1) MX357697B (enExample)
WO (1) WO2013186754A2 (enExample)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013066438A2 (en) 2011-07-22 2013-05-10 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
GB201122458D0 (en) 2011-12-30 2012-02-08 Univ Wageningen Modified cascade ribonucleoproteins and uses thereof
LT3401400T (lt) 2012-05-25 2019-06-10 The Regents Of The University Of California Būdai ir kompozicijos, skirtos rnr molekulės nukreipiamai tikslinės dnr modifikacijai ir rnr molekulės nukreipiamam transkripcijos moduliavimui
EP3135765A1 (en) 2012-12-06 2017-03-01 Sigma-Aldrich Co. LLC Crispr-based genome modification and regulation
SG11201507378UA (en) 2013-03-14 2015-10-29 Caribou Biosciences Inc Compositions and methods of nucleic acid-targeting nucleic acids
US10378027B2 (en) 2013-03-15 2019-08-13 The General Hospital Corporation RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
US10760064B2 (en) 2013-03-15 2020-09-01 The General Hospital Corporation RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
WO2014204578A1 (en) 2013-06-21 2014-12-24 The General Hospital Corporation Using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome editing
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
US9388430B2 (en) 2013-09-06 2016-07-12 President And Fellows Of Harvard College Cas9-recombinase fusion proteins and uses thereof
CN106459995B (zh) 2013-11-07 2020-02-21 爱迪塔斯医药有限公司 使用统治型gRNA的CRISPR相关方法和组合物
US20150166984A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting alpha-antitrypsin point mutations
WO2016022363A2 (en) 2014-07-30 2016-02-11 President And Fellows Of Harvard College Cas9 proteins including ligand-dependent inteins
US10920285B2 (en) 2014-12-03 2021-02-16 Qiagen Gmbh Highly specific and sensitive methods for detecting enterohemorrhagic Escherichia coli serotypes O157:H7 and/or O145:H28
US10233505B2 (en) 2015-01-16 2019-03-19 Kansas State University Research Foundation Co-detection and association of multiple genes from the same genome in a sample
US9512446B1 (en) 2015-08-28 2016-12-06 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
AU2016316845B2 (en) 2015-08-28 2022-03-10 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
US9926546B2 (en) 2015-08-28 2018-03-27 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
SG10202104041PA (en) 2015-10-23 2021-06-29 Harvard College Nucleobase editors and uses thereof
CN105779584A (zh) * 2015-12-18 2016-07-20 珠海出入境检验检疫局检验检疫技术中心 大肠杆菌o111检测用的引物和探针组、试剂盒及pcr检测方法
CN105821124A (zh) * 2016-04-06 2016-08-03 山东省滨州畜牧兽医研究院 一种大肠杆菌 o26、o45、o121血清型三重pcr检测试剂盒及其引物组
KR20250103795A (ko) 2016-08-03 2025-07-07 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 아데노신 핵염기 편집제 및 그의 용도
US11661590B2 (en) 2016-08-09 2023-05-30 President And Fellows Of Harvard College Programmable CAS9-recombinase fusion proteins and uses thereof
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
SG11201903089RA (en) 2016-10-14 2019-05-30 Harvard College Aav delivery of nucleobase editors
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
EP3592381A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Cancer vaccine
US11898179B2 (en) 2017-03-09 2024-02-13 President And Fellows Of Harvard College Suppression of pain by gene editing
WO2018165629A1 (en) 2017-03-10 2018-09-13 President And Fellows Of Harvard College Cytosine to guanine base editor
WO2018176009A1 (en) 2017-03-23 2018-09-27 President And Fellows Of Harvard College Nucleobase editors comprising nucleic acid programmable dna binding proteins
ES2992912T3 (en) 2017-04-21 2024-12-19 Massachusetts Gen Hospital Variants of cpf1 (cas12a) with altered pam specificity
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
AU2018273986A1 (en) 2017-05-25 2019-12-12 The General Hospital Corporation Bipartite base editor (BBE) architectures and type-II-C-Cas9 zinc finger editing
CN111801345A (zh) 2017-07-28 2020-10-20 哈佛大学的校长及成员们 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
EP3676376B1 (en) 2017-08-30 2025-01-15 President and Fellows of Harvard College High efficiency base editors comprising gam
US11795443B2 (en) 2017-10-16 2023-10-24 The Broad Institute, Inc. Uses of adenosine base editors
WO2019118949A1 (en) 2017-12-15 2019-06-20 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
US10101328B1 (en) 2017-12-29 2018-10-16 Clear Labs, Inc. Detection of microorganisms in food samples and food processing facilities
SG11201903333SA (en) * 2017-12-29 2019-08-27 Clear Labs Inc Automated priming and library loading services
US10597714B2 (en) 2017-12-29 2020-03-24 Clear Labs, Inc. Automated priming and library loading device
US12157760B2 (en) 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
EP3820495A4 (en) 2018-07-09 2022-07-20 The Broad Institute Inc. RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES
CN108950033B (zh) * 2018-07-26 2022-01-11 江苏省农业科学院 同时检测肠出血性大肠杆菌o45和o145的纳米pcr试剂盒及其应用
WO2020051301A1 (en) * 2018-09-06 2020-03-12 Hygiena, Llc Sequences and their use for detection and characterization of escherichia coli serotype o157:h7
CN111100862B (zh) * 2018-10-26 2023-09-29 厦门大学 一种检测细菌血清型的方法
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
EP3921417A4 (en) 2019-02-04 2022-11-09 The General Hospital Corporation VARIANTS OF ADENINE DNA BASES WITH REDUCED OFF-TARGET RNA EDIT
EP3942043A2 (en) 2019-03-19 2022-01-26 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
WO2020214842A1 (en) 2019-04-17 2020-10-22 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
BR112022022603A2 (pt) 2020-05-08 2023-01-17 Broad Inst Inc Métodos e composições para edição simultânea de ambas as fitas de sequência alvo de nucleotídeos de fita dupla
US20230279442A1 (en) 2021-12-15 2023-09-07 Versitech Limited Engineered cas9-nucleases and method of use thereof
CN116903710B (zh) * 2023-09-12 2023-11-14 山东省农业科学院畜牧兽医研究所 噬菌体靶向蛋白分子及其在鉴定o103抗原血清型的产志贺毒素大肠杆菌中的应用
WO2026006542A2 (en) 2024-06-26 2026-01-02 Yale University Compositions and methods for crispr/cas9 based reactivation of human angelman syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002355074A (ja) * 2001-01-24 2002-12-10 Univ Tsukuba 腸管出血性病原性大腸菌o157:h7に特異的な核酸分子およびポリペプチド並びにこれらの使用方法
US20060051751A1 (en) * 2002-01-23 2006-03-09 Gehua Wang Major virulence factor detection and verocytontoxin type 2 subtype from clinical e. coli isolates using a one-step multiplex pcr
EP2292799A1 (en) 2009-08-11 2011-03-09 Agence Française de Securité Sanitaire des Aliments An assay for determining a molecular risk assessment of stec isolates

Also Published As

Publication number Publication date
CN104619860B (zh) 2018-01-30
JP2015519075A (ja) 2015-07-09
MX2014015130A (es) 2015-08-06
CA2875919A1 (en) 2013-12-19
US20150176064A1 (en) 2015-06-25
ES2659469T3 (es) 2018-03-15
KR20150030783A (ko) 2015-03-20
AU2013276084A1 (en) 2015-01-29
JP6166365B2 (ja) 2017-07-19
BR112014031370A2 (pt) 2017-07-25
WO2013186754A3 (en) 2014-02-20
AU2013276084B2 (en) 2019-04-04
US10190175B2 (en) 2019-01-29
WO2013186754A2 (en) 2013-12-19
BR112014031370B1 (pt) 2022-06-07
EP2861762B1 (en) 2017-12-13
EP2674501A1 (en) 2013-12-18
EP2861762A2 (en) 2015-04-22
AU2013276084A8 (en) 2015-02-12
CA2875919C (en) 2021-08-31
KR102065053B1 (ko) 2020-01-10
CN104619860A (zh) 2015-05-13
MX357697B (es) 2018-07-19

Similar Documents

Publication Publication Date Title
BR112014027348A2 (pt) compostos agonistas duplos gip-glp-1 e métodos
CL2016001080A1 (es) Benzamidas sustituidas para tratamiento de artrópodos.
LT3702351T (lt) Kompozicijos, apimančios mek inhibitorių
DK2854632T3 (da) Perception loss detection
DK3466930T3 (da) Fødevareprodukt med reduceret natriumindhold
DK3057822T3 (da) Rulleleje
PT2876446T (pt) Método para deteção de cancro
DK2988874T3 (da) Valseværk
CL2016001153A1 (es) Vacuna para peces.
LT2975022T (lt) Naujas hidroksamo rūgšties darinys arba jo druska
PT3082454T (pt) Método para processamento de vegetais
BR112015014884A2 (pt) método para identificar, polinucleotídeo isolado e kit
DK3053240T3 (da) AC-MOSFET-kontakt med fire segmenter
BR112014028502A2 (pt) aparato para pesca.
GB201303206D0 (en) Ownership Detection Method
FR3002126B1 (fr) Mobilier roulant dissociable
ES1106805Y (es) Bovedilla insonora para forjados
BR112015001077A2 (pt) unidade de resfriamento submarina e método de resfriamento.
ES1076551Y (es) Abrefacil para botes
ES1076467Y (es) Pinza para la manipulación de alimentos
ES1078738Y (es) Bovedilla para forjados.
TH1401007859A (th) อาหารสัตว์น้ำจำพวกมีเปลือก
ES1078999Y (es) Dispositivo para monitorizar la corrosion.
UA27090S (uk) Пуфик кований круглий
ES1080629Y (es) Barbacoa